DD297916A5 - Niedrig-viskose, hochkonzentrierte surfactant-suspensionen - Google Patents

Niedrig-viskose, hochkonzentrierte surfactant-suspensionen Download PDF

Info

Publication number
DD297916A5
DD297916A5 DD90342432A DD34243290A DD297916A5 DD 297916 A5 DD297916 A5 DD 297916A5 DD 90342432 A DD90342432 A DD 90342432A DD 34243290 A DD34243290 A DD 34243290A DD 297916 A5 DD297916 A5 DD 297916A5
Authority
DD
German Democratic Republic
Prior art keywords
mmol
surfactant
ions
calcium
suspensions
Prior art date
Application number
DD90342432A
Other languages
German (de)
English (en)
Inventor
Bernd Disse
Eberhard Weller
Robert Becker
Original Assignee
��K@����@������@������������@���@�������������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��K@����@������@������������@���@�������������@�������k�� filed Critical ��K@����@������@������������@���@�������������@�������k��
Publication of DD297916A5 publication Critical patent/DD297916A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Artificial Filaments (AREA)
  • Colloid Chemistry (AREA)
DD90342432A 1989-07-04 1990-07-02 Niedrig-viskose, hochkonzentrierte surfactant-suspensionen DD297916A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension

Publications (1)

Publication Number Publication Date
DD297916A5 true DD297916A5 (de) 1992-01-30

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90342432A DD297916A5 (de) 1989-07-04 1990-07-02 Niedrig-viskose, hochkonzentrierte surfactant-suspensionen

Country Status (24)

Country Link
US (1) US5552161A (es)
EP (1) EP0406732B1 (es)
JP (1) JP3103582B2 (es)
KR (1) KR0162642B1 (es)
AT (1) ATE122891T1 (es)
AU (1) AU623538B2 (es)
CA (1) CA2020209C (es)
DD (1) DD297916A5 (es)
DE (2) DE3921954A1 (es)
DK (1) DK0406732T3 (es)
ES (1) ES2072940T3 (es)
FI (1) FI95655C (es)
HK (1) HK1000277A1 (es)
HU (1) HU205004B (es)
IE (1) IE68448B1 (es)
IL (1) IL94961A (es)
NO (1) NO180620C (es)
NZ (2) NZ242869A (es)
PH (1) PH30232A (es)
PL (1) PL164434B1 (es)
PT (1) PT94574B (es)
RU (1) RU2077880C1 (es)
UA (1) UA26313A (es)
ZA (1) ZA905182B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
EP1249244A1 (en) 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
JP4559731B2 (ja) 2001-10-11 2010-10-13 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺サーファクタントの新規使用
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006121064A1 (ja) * 2005-05-11 2006-11-16 Yamasa Corporation 肺サーファクタント蛋白質の安定化法
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
EP0110498B2 (en) * 1982-11-22 1991-09-18 Teijin Limited Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
NO902961D0 (no) 1990-07-03
IL94961A0 (en) 1991-06-10
EP0406732A2 (de) 1991-01-09
AU623538B2 (en) 1992-05-14
NZ242869A (en) 1997-05-26
EP0406732B1 (de) 1995-05-24
HU205004B (en) 1992-03-30
NZ234341A (en) 1992-07-28
PT94574B (pt) 1997-02-28
NO180620B (no) 1997-02-10
HU904077D0 (en) 1990-12-28
FI95655C (fi) 1996-03-11
CA2020209C (en) 2000-09-12
KR0162642B1 (ko) 1998-12-01
KR910002427A (ko) 1991-02-25
DK0406732T3 (da) 1995-10-02
JPH0344332A (ja) 1991-02-26
ATE122891T1 (de) 1995-06-15
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
NO902961L (no) 1991-01-07
UA26313A (uk) 1999-08-30
CA2020209A1 (en) 1991-01-05
RU2077880C1 (ru) 1997-04-27
IE68448B1 (en) 1996-06-26
PT94574A (pt) 1991-03-20
DE3921954A1 (de) 1991-01-17
JP3103582B2 (ja) 2000-10-30
EP0406732A3 (en) 1991-02-27
NO180620C (no) 1997-05-21
DE59009113D1 (de) 1995-06-29
PH30232A (en) 1997-02-05
PL164434B1 (pl) 1994-07-29
FI95655B (fi) 1995-11-30
ES2072940T3 (es) 1995-08-01
AU5867690A (en) 1991-01-10
HK1000277A1 (en) 1998-02-20
ZA905182B (en) 1992-03-25
HUT56274A (en) 1991-08-28
US5552161A (en) 1996-09-03
IE902408A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
DE2601207C3 (de) Verfahren zur Herstellung einer flüssigen pharmazeutischen Zubereitung mit gesteuertem Arzneimittelabgabevermögen
DE3021006C2 (de) Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung
EP0100910B1 (de) Lungensurfactant
DE3008082A1 (de) Carcinostatisches und die immunreaktion stimulierendes mittel, enthaltend lysophospholipid und phospholipid, und verfahren zur herstellung desselben
EP0616801A1 (de) Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
DE3512926A1 (de) Verbesserung in oder bezueglich der therapie mit interleukin
EP0733372A2 (de) Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
EP0406732B1 (de) Niedrig-viskose, hochkonzentrierte Surfactant-Suspension
DE102010028365A1 (de) Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen
DE69928279T2 (de) Lungensurfactant zubereitungen enthaltendes behandlungset
DE1195905B (de) Verfahren zum Abtrennen der Zellwaende von Mycobacterium phlei
EP0145005B1 (de) Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE3115080A1 (de) Arzneimittel fuer die orale verabreichung und verfahren zu seiner herstellung
AT397460B (de) Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
EP0181287B1 (de) Trockensubstanzen und stabile Suspensionen
DE2234832C2 (de) Proteinfreies Hormonkonzentrat von Säugetier-Nebenschilddrüsen, dessen Herstellung und dieses Hormonkonzentrat enthaltende pharmazeutische Präparate
EP0470437B1 (de) Wässriges Liposomensystem
DE1620629C3 (de) Verwendung eines Salzes von 2-Merkaptoäthansulf onsäure zur Herstellung von Mukolytica
DE68903670T2 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
DE2546001A1 (de) Immunostimulierende phospholipide und sie enthaltende arzneimittel
DE1617279A1 (de) Verfahren zur Herstellung pharmazeutischer Praeparate zur Verhinderung der Bildung von Blutgerinnseln
EP0123142B1 (de) Verfahren zur Stabilisierung von Hämatin
DE19729641C2 (de) Antihämolytische liposomale Zubereitung und Verfahren zu deren Herstellung
DE3827472A1 (de) Verfahren zum herstellen einer waessrigen loesung von lysin-(alpha)-methyl-4-(2'-thienylcarbonyl)phenylacetat fuer die oertliche anwendung in der augenheilkunde
DE19851617A1 (de) Behandlungsset

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee